According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is $0.46. In 2022 the company made an earnings per share (EPS) of $0.65 a decrease over its 2021 EPS that were of $1.26.
Year | EPS | Change |
---|---|---|
2023 (TTM) | $0.46 | -28.72% |
2022 | $0.65 | -48.38% |
2021 | $1.26 | 129.33% |
2020 | $0.55 | 1194.61% |
2019 | $0.04246 | -93.1% |
2018 | $0.62 | -43.22% |
2017 | $1.08 | 33.37% |
2016 | $0.81 | -236.78% |
2015 | -$0.59 | -294.41% |
2014 | $0.31 | -66.04% |
2013 | $0.90 | 9.95% |
2012 | $0.82 | -46.86% |
2011 | $1.54 | -18.07% |
2010 | $1.88 | -13.68% |
2009 | $2.18 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $14.09 | 2,936.80% | ๐บ๐ธ USA |
Novartis NVS | $3.74 | 706.35% | ๐จ๐ญ Switzerland |
Pfizer PFE | $1.86 | 301.02% | ๐บ๐ธ USA |
Amgen AMGN | $14.15 | 2,950.75% | ๐บ๐ธ USA |
Sanofi SNY | $3.18 | 585.66% | ๐ซ๐ท France |
Merck MRK | $1.82 | 292.76% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $3.50 | 654.76% | ๐ฌ๐ง UK |
Seagen
SGEN | -$4.01 | -964.56% | ๐บ๐ธ USA |
Dr. Reddy's RDY | $3.71 | 700.10% | ๐ฎ๐ณ India |